PT Sun Life Indonesia kicked off the first quarter of 2026 with an exceptional financial performance, recording a net profit of IDR 97.05 billion. This remarkable figure represents a substantial 104.7% increase compared to the same period last year. The significant surge in profit for the life insurance company was primarily driven by the robust strengthening of its distribution channels, notably through strategic banking partnerships and a thriving agency network.
This strong growth trajectory was further underscored by an impressive rise in total company revenue, which climbed from IDR 388.23 billion to IDR 505.76 billion. Concurrently, premium income witnessed a substantial boost, escalating to IDR 944.94 billion from the previous IDR 633.94 billion, highlighting the company’s expanding market reach and customer acquisition efforts.
Albertus Wiroyo, President Director of Sun Life Indonesia, emphasized that this stellar performance is a clear reflection of the escalating customer trust in Sun Life Indonesia’s products and services. Speaking at the SHIFA Signature press conference on Friday, May 9, Albertus stated, “This performance reflects continuously growing trust, and it is Sun Life Indonesia’s responsibility to keep delivering solutions that are relevant to the needs of society today.”
Indeed, the need for comprehensive health protection in Indonesia is more critical than ever, with health risks and medical costs consistently on the rise. Data reveals a concerning trend, with medical cost inflation in Indonesia reaching a staggering 19.8% in 2025. Adding to this challenge, critical illnesses are increasingly affecting individuals in their productive years, with many cases emerging in those under 40.
Compounding these issues is Indonesia’s persistently low life insurance penetration, which remains below 3% of the Gross Domestic Product (GDP). Currently, only approximately 6.6% of the Indonesian population holds life insurance, signaling a vast, underserved market hungry for reliable protection.
In response to these pressing societal needs, Sun Life has proudly launched its innovative new health product, SHIFA Signature. This meticulously designed offering serves as a crucial complement to family health protection, providing enhanced coverage even for customers who already possess protection from BPJS or corporate insurance plans.
SHIFA Signature boasts a wide array of benefits, including inpatient and surgical care, outpatient services for medical procedures, ambulance services, and specific vaccinations. It also provides a death benefit and a suite of additional advantages such as telehealth services, home care, health screenings for stroke and cancer, and coverage for certain traditional medical treatments in accordance with policy terms. Customers have the flexibility to select from seven protection regions, ranging from Indonesia-only coverage to comprehensive global protection. The product offers annual health benefits of up to IDR 15 billion, with an optional Limit Booster that can extend coverage up to IDR 35 billion, demonstrating its commitment to extensive protection.
Albertus affirmed that SHIFA Signature was conceived to address the increasingly diverse and evolving needs of the community, providing tailored solutions for peace of mind. The product is strategically distributed through Sun Life Indonesia’s extensive agency channels and robust banking partnerships, including collaborations with PT Bank CIMB Niaga Tbk, CIMB Niaga Syariah, and Bank Muamalat Indonesia, ensuring broad accessibility for prospective customers.
Further highlighting Sun Life’s overall robust performance, its Syariah business unit also delivered impressive results. Sun Life Syariah recorded a net profit after tax of IDR 28.29 billion, representing an astounding 259.46% leap compared to Q1 2025’s IDR 7.87 billion. The unit’s net contribution similarly saw a significant rise, increasing from IDR 68.43 billion to IDR 83.77 billion, solidifying its positive trajectory within the market.
Summary
Sun Life Indonesia achieved a significant financial milestone in the first quarter of 2026, recording a net profit of IDR 97.05 billion, which marks a 104.7% increase year-on-year. This growth was driven by expanded distribution channels and a substantial rise in total revenue and premium income. Furthermore, the company’s Syariah business unit demonstrated exceptional performance, achieving a 259.46% surge in net profit after tax compared to the same period in 2025.
To address rising medical cost inflation and the critical need for comprehensive health coverage in Indonesia, the company launched its new product, SHIFA Signature. This offering provides flexible and extensive protection, including global coverage and benefits of up to IDR 35 billion, accessible through strategic banking and agency partnerships. By introducing such tailored solutions, Sun Life aims to enhance customer trust and address the underserved life insurance market as demand for robust health protection continues to grow.
